News

Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review.

A. SPINI, G. ROBERTO, R. GINI, C. BARTOLINI, L. BAZZANI, S. DONNINI, S. CRISPINO, M. ZICHE. Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review. Neoplasma 2019; 66(6): 963–970 963, doi:10.4149/neo_2019_190110N34

28 March 2019

Annual Impact Sheet 2018 published!

18 March 2019

Tumour-reactive T cell subsets in the microenvironment of ovarian cancer

Marie Christine Wulff Westergaard, Rikke Andersen, Chloé Chong, Julie Westerlin Kjeldsen, Magnus Pedersen, Christina Friese, Thomas Hasselager, Henrik Lajer, George Coukos, Michal Bassani-Sternberg, Marco Donia, Inge Marie Svane. Tumour-reactive T Cell Subsets in the Microenvironment of Ovarian Cancer. British Journal of Cancer. 2019 Feb;120(4):424-434. doi: 10.1038/s41416-019-0384-y. Epub 2019 Feb 5.

5 February 2019

A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer

Tuyaerts, S., Rombauts, K., Everaert, T., Van Nuffel, AMT. and Amant, F. (2019). A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer. Front. Nutr. 5:138. doi: 10.3389/fnut.2018.00138

11 January 2019